Acer Medical Inc. (TPEX:6857)
Taiwan · Delayed Price · Currency is TWD 90.00
0.00 (-1.64%)
Sep 4, 2026, 12:58 PM CST
Acer Medical Market Cap
Acer Medical has a market cap or net worth of 1.37 billion as of September 4, 2026. Its market cap has decreased by -20.00% in one year.
Market Cap
1.37B
Enterprise Value
1.22B
Revenue
70.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
90.00
ChartMarket Cap Chart
Since October 27, 2021, Acer Medical's market cap has increased from 720.00M to 1.37B, an increase of 90.33%. That is a compound annual growth rate of 14.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 1.37B | -9.09% |
| Dec 31, 2025 | 1.51B | -30.28% |
| Dec 30, 2024 | 2.16B | -23.66% |
| Dec 29, 2023 | 2.83B | 154.79% |
| Dec 30, 2022 | 1.11B | -1.98% |
| Dec 21, 2021 | 1.13B | 57.50% |
| Oct 27, 2021 | 720.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 549.12B |
| Lin BioScience | 144.70B |
| Caliway Biopharmaceuticals | 132.52B |
| Pell Bio-Med Technology | 87.93B |
| Andros Pharmaceuticals Co.,Ltd | 1.45B |
| NaviFUS | 1.44B |
| U-Neuron Biomedical | 1.43B |
| TaiRx | 1.41B |